USD 127.48 billion
Report ID:
SQMIG35J2035 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
145
|Figures:
81
Automated Cell Imaging System Market size was valued at USD 127.48 billion in 2023 and is poised to grow from USD 137.93 billion in 2024 to USD 259.11 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).
The market is growing at a healthier rate and is expected to grow faster. It is due to an increase in the number of chronic patients across the world. The increase in investment for research and development of new drugs and vaccines is also driving the market growth. However high cost of maintenance and less availability of spare parts is hampering the growth of the automated cell imaging system market.
North-America holds the maximum share across the globe. It is due to early usage of advanced technology in the healthcare sector. The USA is the major country in the region. The Asia-Pacific region is growing at a faster rate due to high investment in the healthcare sector.
US Automated Cell Imaging System Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 127.48 billion
Largest Segment
Hospitals
Fastest Growth
Research & Diagnostic Laboratories
Growth Rate
8.2% CAGR
To get more reports on the above market click here to Buy The Report
Global Automated Cell Imaging System Market is segmented by Product, Application, Technology, End User and region. Based on Product, the market is segmented into Instruments, Consumables, Software and Services. Based on Application, the market is segmented into Drug Discovery, Diagnostics, Biological and Biomedical Research and Other Applications. Based on Technology, the market is segmented into Fluorescence Imaging, Brightfield Imaging, High-Content Screening and Other Technologies. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals, Diagnostic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
By product, time-lapse technology held the maximum share in 2022. It is because the technique allows image sequences to be viewed during acquisition. The time intervals between image capture can simply be preset on the camera being used or integrated camera microscope software which gives high resolution images. It is mostly used to look at the stages of embryo in IVF. It is also used widely in cell biology to observe artificially cultured cells.
By end user, the hospital segment held the largest share in 2022. The increasing use in IVF diagnostic tests and rising number of hospitals due to rapid developments in the healthcare sector is driving the growth. The rise in chronic diseases due to environmental pollution is creating a demand for hospitals.
To get detailed analysis on other segments, Request For Free Sample Report
North America holds the largest market share across the world. It is due to technological advancement in the healthcare industry. The USA has one of the highest and advanced diagnostic laboratories across the globe. The main driver in the region is an extensive patient base. Due to high consumption of alcohol and obesity the number of cancer patients are increasing. According to a report, the USA has projected 6,09,360 cancer deaths in 2022.
The Asia-Pacific region is growing at a faster rate due to rapid development in the healthcare sector of the region. There is an increasing investment in research and development of new technologies. The growing economies like India and China have the largest market share in the region. The growing demand for regenerative medicine research and increasing government initiative for stem cell therapy is driving the growth of the market.
Europe is growing at a steady rate due to early adoption of technology. Due the presence of well-developed research centers and facilities in the region the market is expected to witness a growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increase in Rate of Cancer
High maintenance Cost
Request Free Customization of this report to help us to meet your business objectives.
The market is controlled by a few manufacturers. The product requires a huge amount of capital to be invested for setting up and also on research & development. Due to low competition the prices have been high. Major manufacturers include- General Electric Company, Olympus Corporation, PerkinElmer Inc., Sartorius AG, and Thermo Fisher Scientific. These major manufacturers having advanced proprietary products are getting an edge over the other market players.
Automated Cell Imaging System Market Top Company Profiles
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, the advantages of automated cell imaging systems such as the ability to predict certain cancers, reduced time and cost needed for testing and reduction of uncertainty in disease characterization drives the market growth. North America held the dominant share in this market in 2022 but Asia Pacific is projected to emerge as the fastest growing market in the forecast period. Major manufacturers are partnering with different companies to introduce new technology which is easier and efficient than the older ones. However due to the presence of less number of companies the prices of the product are very high as there is a supply side deficit.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 127.48 billion |
Market size value in 2032 | USD 259.11 billion |
Growth Rate | 8.2% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Automated Cell Imaging System Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Automated Cell Imaging System Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Automated Cell Imaging System Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Automated Cell Imaging System Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Automated Cell Imaging System Market size was valued at USD 118.37 Billion in 2023 and is poised to grow from USD 128.67 Billion in 2024 to USD 250.79 Billion by 2032, growing at a CAGR of 8.70% during the forecast period (2025-2032).
The market is controlled by a few manufacturers. The product requires a huge amount of capital to be invested for setting up and also on research & development. Due to low competition the prices have been high. Major manufacturers include- General Electric Company, Olympus Corporation, PerkinElmer Inc., Sartorius AG, and Thermo Fisher Scientific. These major manufacturers having advanced proprietary products are getting an edge over the other market players. 'Thermo Fisher Scientific Inc.', 'Carl Zeiss AG', 'Olympus Corporation', 'GE Healthcare', 'Leica Microsystems GmbH', 'PerkinElmer, Inc.', 'Nikon Corporation', 'Molecular Devices LLC', 'BD Biosciences', 'BioTek Instruments, Inc.', 'Sartorius AG', 'Agilent Technologies, Inc.', 'Tecan Group AG', 'Bruker Corporation', 'Merck KGaA', 'Yokogawa Electric Corporation', 'Hamilton Company', 'Danaher Corporation', 'Sysmex Corporation', 'Bio-Rad Laboratories, Inc.', 'In February 2024, Tecan unveiled end-to-end cellomics workflow solutions, including cell seeding and culture with quality control and monitoring, through drug dosing to live-cell imaging and analysis. This comprehensive offering enables laboratories to improve the reliability, reproducibility and throughput of their workflows, addressing key challenges in the growing field of 3D cell biology. ', 'In February 2024, in separate transactions, Bruker acquired preclinical in-vivo optical imaging systems company Spectral Instruments Imaging (SII), and Nanophoton Corporation, a provider of advanced research Raman microscopy systems. ', 'In October 2023, Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation, launched the CellXpress.ai™ Automated Cell Culture System—an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab.'
Due to changes in lifestyle and radiation our body shows some deformities in genes. This creates irregular division of cell leading to Tumors. The exposure of certain chemicals to water, food, and soil also causes cancer. Development of new types of cancer also requires automated cell imaging systems to identify the dynamics and functions of telomeric repeat-containing RNA. Automated cell imaging is becoming popular and unique tool for cellular research by looking at digital microscopic images of cancerous cell.
Major pharmaceutical companies are investing on new technologies highly to find new vaccine and drugs. Automated cell imaging systems help the researchers by minimizing the human error and time needed for human intervention in experiments having long durations, large chemical libraries, or both. The system acquires and analyzes high resolution images.
North America holds the largest market share across the world. It is due to technological advancement in the healthcare industry. The USA has one of the highest and advanced diagnostic laboratories across the globe. The main driver in the region is an extensive patient base. Due to high consumption of alcohol and obesity the number of cancer patients are increasing. According to a report, the USA has projected 6,09,360 cancer deaths in 2022.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35J2035
[email protected]
USA +1 351-333-4748